Molecular Imaging

Nuclear imaging, also called molecular imaging, includes positron emission computed tomography (PET) and single photon emission computed tomography (SPECT) imaging. This section includes radiopharmaceuticals and tracers, PET-CT, SPECT-CT, and PET-MRI. Molecular imaging includes the field of nuclear medicine, which uses very small amounts of radioactive materials, or radiopharmaceuticals, to diagnose and treat disease.

World's First Digital SPECT/CT Capable of High Energy Imaging Enables Full Range of Clinical Capabilities to Nuclear Medicine Centers
October 18, 2022 — Spectrum Dynamics announced its newest development in digital nuclear medicine imaging: the capability to image high energy isotopes using solid-state detector technology in a 3600-CZT based, wide-bore …
Top 10: September's Most-read Content
Here is a recap of what ITN viewers found most interesting during the month of September:

1. Lasting Lung Damage Seen in Children and Teens after COVID
New ASNC-led Guideline Details How to Use CT in Hybrid Nuclear-CT Cardiac Imaging
September 7, 2022 — The American Society of Nuclear Cardiology (ASNC) and three partner societies have come together to answer cardiac imagers’ questions…
Raymond V. Damadian, MD, Recognized as “The Father of MRI” Dies at 86
August 10, 2022 — The imaging community has lost a legend, recognized for having revolutionized the field of diagnostic medicine.
Fresenius Kabi Introduces Generic Iodixanol Contrast Media Agent
July 18, 2022 — Fresenius Kabi announced today it will introduce a portfolio of generic contrast media agents in the United States, starting…

Researchers at the University of Wisconsin–Madison will kick off research scanning human subjects with GE Healthcare’s latest generation PCCT prototype in December 2022, representing the first U.S. clinical evaluation site with GE Healthcare’s pure silicon CT detector technology

News | Proton Therapy

UW–Madison To Perform the First U.S. Evaluation of GE Healthcare’s Photon Counting CT Technology with Deep Silicon Detectors

November 25, 2022 — Researchers at the University of Wisconsin–Madison, the first U.S. clinical evaluation site for GE ...

November 25, 2022

Simulations by Rice University engineers have revealed details about the molecular interactions between gadolinium contrast agents used in MRI scans and their liquid environment. In this model, green gadolinium is surrounded by blue chelate ions, themselves surrounded by water (gray oxygen and red hydrogen atoms). Thiago Pinheiro dos Santos/Rice University

News | Magnetic Resonance Imaging (MRI)

Rice Refines Analysis of MRI Contrast Agents

November 21, 2022 — You can keep your best guesses. Engineers at Rice University’s George R. Brown School of Engineering ...

November 21, 2022

Figure 1. The fat pad adjacent to the kneecap (Hoffa's fat pad, infrapatellar fat pad) can change in signal on MRI when the knee is inflamed. (A) Normal knee without signs of inflammation. (B) Arrow pointing on a circumscribed area with higher signal (bright lines) in the area of the fat pad (normally dark), which is indicative of a beginning inflammatory reaction. (C) The whole fat pad has a higher signal (light grey color with white lines), which is a sign of progressive inflammation of the knee joint.

News | RSNA

NSAIDs May Worsen Arthritis Inflammation

November 21, 2022 — Taking anti-inflammatory pain relievers like ibuprofen and naproxen for osteoarthritis may worsen ...

November 21, 2022

Sponsored Content

Staging F-18 FDG PET/CT images of adenocarcinoma in the RUL of the lung illustrates the value of Vereos. The primary lesion in the right upper lobe appears in the upper row (PET image is left, CT image is right). A 3 mm synchronous primary or metastatic lesion in the RUL is apparent in the lower row. The precision afforded by Vereos' images provided the basis for the patient to undergo RUL lobectomy instead of thermal ablation of the primary lesion. Images courtesy of Dr. Jay Kikut and UVM

Blog | PET-CT

Digital PET Balances Scan Time and Resolution

Efficiency and effectiveness are inseparable in clinical medicine. Digital PET addresses them both. The key is the ...

October 25, 2018

Top trends boosting the industry expansion through 2028

Feature | Contrast Media | By Shankar Khatkale

Imaging Contrast Agents Global Market Outlook

According to a recent study from market research firm Graphical Research, the global imaging agents market size is set ...

November 02, 2022

The oral presentation includes additional results from Blue Earth's Phase 3 SPOTLIGHT study evaluating the impact of clinical factors on the detection rate of 18F-rhPSMA-7.3 PET imaging in men with suspected prostate cancer recurrence based on elevated PSA following prior therapy

News | PET Imaging

Blue Earth Diagnostics Highlights Presentations on Axumin (Fluciclovine F 18) and Investigational 18F-rhPSMA-7.3 in Biochemically Recurrent Prostate Cancer

October 25, 2022 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...

October 25, 2022

Company announces SCINTIX as new product name for its flagship biology-guided radiotherapy technology

News | PET-CT

RefleXion Highlights New Cancer Treatment Research Abstracts for Presentation at ASTRO 2022

October 24, 2022 — RefleXion Medical, a therapeutic oncology company pioneering biology-guided radiotherapy* (BgRT) as a ...

October 24, 2022

18F-SMBT-1 PET studies showed that beta-amyloid+ Alzheimer’s disease (AD) patients, but most importantly, beta-amyloid+ controls (CN) have significantly higher regional 18F-SMBT-1 binding than beta-amyloid- CN, with 18F-SMBT-1 retention highly associated with beta-amyloid burden. These findings suggest that increased 18F-SMBT-1 binding is detectable at the preclinical stages of beta-amyloid accumulation.

News | PET Imaging

Novel PET Imaging Agent Detects Earliest Signs of Alzheimer's Disease

October 20, 2022 — A new highly selective PET imaging agent can detect the presence of overexpressed monoamine oxidase-B ...

October 20, 2022

Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today announced the signing of a data-sharing agreement with Siemens Healthineers and the University Hospital of the Technical University of Munich (TUM) for anonymized 18F-rhPSMA-7.3 clinical data and images.

News | PET Imaging

Blue Earth Diagnostics Announces Data-sharing Agreement with Siemens Healthineers and the University Hospital of Technical University of Munich (TUM) for 18F-rhPSMA-7.3

October 19, 2022 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...

October 19, 2022

Based on Spectrum Dynamics digital SPECT/CT platform, VERITON-CT 400 Series provides the benefits of increased sensitivity and throughput to clinical applications based on high energy isotopes used in Nuclear Medicine

News | SPECT-CT

World's First Digital SPECT/CT Capable of High Energy Imaging Enables Full Range of Clinical Capabilities to Nuclear Medicine Centers

October 18, 2022 — Spectrum Dynamics announced its newest development in digital nuclear medicine imaging: the ...

October 18, 2022

Mirion Technologies, Inc., a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced the appointment of Michael Rossi as the President of Mirion Medical. Michael will report directly to Mirion’s CEO, Tom Logan, who had been acting as President of the business segment.

News | Quality Assurance (QA)

Mirion Technologies Appoints Michael Rossi as President of Mirion Medical

October 7, 2022 — Mirion Technologies, Inc., a global provider of radiation detection, measurement, analysis and ...

October 07, 2022

The center will be equipped with a Cyclone KIUBE offering the highest production capacity with a PET cyclotron.

News | Radiopharmaceuticals and Tracers

ElsMed, Novatec and IBA Sign Contract to Install Radiopharmaceutical Production Center in Georgia

October 6, 2022 — IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology and the ...

October 06, 2022

Free-breathing phase-resolved functional lung (PREFUL) low-field MRI at 0.55T with calculated parameters at an axial plane after automatic registration to a mid-expiration position and lung parenchyma segmentation. From left to right, representative color-coded images of functional show ventilation defects (VDP, blue), perfusion defects (QDP, red), ventilation/perfusion (V/Q match, green), ventilation/perfusion defects (V/Q defect, purple) in a healthy control (upper row, 7-year-old male), a participant rec

Feature | Radiology Business

Top 10: September's Most-read Content

Here is a recap of what ITN viewers found most interesting during the month of September: 1. Lasting Lung Damage Seen in ...

October 03, 2022

News | PET Imaging

Blue Earth Diagnostics Announces FDA Acceptance of New Drug Application for 18F-rhPSMA-7.3, a Radiohybrid Prostate-Specific Membrane Antigen-Targeted PET Imaging Agent for Prostate Cancer

September 28, 2022 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...

September 28, 2022

Ground-breaking research funded by National Cancer Institute

News | PET-CT

Xoran Partners With WVU to Develop PET/CT Scanner for Head and Neck Cancers (HNCs)

September 28, 2022 — Xoran Technologies is engaged in a ground-breaking research project to develop a PET/CT scanner for ...

September 28, 2022

IBA Rhodotron TT300-HE electron beam accelerator (Photo: Business Wire)

News | Radiopharmaceuticals and Tracers

NorthStar Medical Radioisotopes and IBA Sign Agreement for Two Additional Rhodotron Electron Beam Accelerators for Commercial Production of Radioisotopes

September 22, 2022 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

September 22, 2022

As the world, particularly the imaging community, is aware, disruptions in a pharmaceutical supply chain have impacted the global availability, and shortage of, iohexol iodinated contrast media (ICM), a common agent used in a multitude of CT and X-ray exams.

Feature | Contrast Media | By Christine Book

Contrast Media Supply Shortage: How and What Now?

The theme “Everyday progress” seems appropriate for the imaging community in 2022. What a year it’s been. Supply ...

September 14, 2022

For over 40 years the vision of Shared Medical Services (SMS) has been to provide innovative imaging and service solutions to healthcare facilities regardless of their size, location or capital budget. That vision is as strong today as it was back in 1980.

News | PET-CT

SMS first to bring Mobile Digital PET/CT to North Dakota and Montana

September 13, 2022 — For over 40 years the vision of Shared Medical Services (SMS) has been to provide innovative ...

September 13, 2022